Willingness to participate in South African HIV vaccine trials - Concerns of medical professionals in the Western Cape

South African Medical Journal

Volumn 92, Issue 11, 2002, Pages 904-906

  Moodley, Keymanthri ^a   Barnes, Jo ^a   van Rensburg, Estrelita Janse ^a   Myer, Landon ^b,c  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HEALTH CARE PERSONNEL; HOSPITAL PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICAL PROFESSION; MOTIVATION; PATIENT COMPLIANCE; POSTAL MAIL; SOUTH AFRICA;

ADULT; AIDS VACCINES; ATTITUDE OF HEALTH PERSONNEL; CLINICAL TRIALS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT SELECTION; PERSONNEL SELECTION; PHYSICIANS; SOUTH AFRICA;

EID: 0036856622     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Slack C, Lindegger G, Vardas E, Richter L, Strode A, Wassenaar D. Ethical issues in HIV vaccine trials in South Africa. South African Journal of Science 2000; 291-295.
2. Makgoba MW, Solomon N, Tucker TJ. The research for an HIV vaccine. BMJ 2002; 324: 211-213.
3. Jenkins RA, Temoshok LR, Virochsiri K. Incentives and disincentives to participate in prophylactic HIV vaccine research. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 36-42.
4. Koblin BA, Heagerty P, Sheon A, et al. Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS 1998; 12: 785-793.
5. Dillman DA. Mail and Internet Surveys: The Tailored Design Method. 2nd ed. New York: John Wiley and Sons, 2000.
6. Connett H. South African village prepares for first HIV vaccine trial. Nat Med 2000; 6: 1199-1200.
7. Frohlich J. Community education: an essential element to effective community participation in the development and research of HIV/AIDS vaccines. Paper [ThPpC1500] presented at the XII International AIDS conference, Durban, 9 - 14 July 2000.
8. D'Adesky A-C. Soweto: A Seasoned Clinical Trials Site Looks To Vaccines. IAVI Report. 2000/1, December 2000 - January 2001.
9. South African HIV Vaccine Action Campaign (HIVAC). http://www.sahealthinfo.org/hivaids/sahivac.htm (accessed 5 May 2002).
10. Giami A, Lavigne C, Linard F, et al. Volunteers' motivation for participating in an HIV vaccine trial. Paper presented at the IX International AIDS conference, Berlin 7 - 11 June 1993.
11. Jenkins RA, Torugsa K, Markowitz LE, et al. Willingness to participate in HIV-1 vaccine trials among young Thai men. Sex Transm Infect 2000; 76: 386-392.
12. Koblin BA, Holte S, Lenderking B Heagerty P. Readiness for HIV vaccine trials: Changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team. J Acquir Immune Defic Syndr 2000; 24: 451-457.
13. Jackson DJ, Martin HL, Bwayo JJ, et al. Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya. AIDS 1995; 9: 1279-1283.